AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
IND Edition 
⚠
✓
Establishment Labs Holdings Inc (NASDAQ:ESTA)
72.41 USD
+2.000 2.841%Sponsored Reports
Loading...
| Previous Close (in USD) | 70.41 |
|---|---|
| Change | +2.000 2.841% |
| 52 W H/L (in USD) | 83.310/28.890 |
| EBITDA (in USD) | -29.445M |
| PE Ratio | -- |
| Volume | 276863 |
| Diluted Eps TTM | -1.72 |
| Total Assets (in USD) | 357.167M |
|---|---|
| Total Liabilities (in USD) | 333.62M |
| Revenue TTM (in USD) | 211.076M |
| Cash (in USD) | 75.572M |
| Market Cap (in USD) | 1,882.394 M |
| Revenue Per Share TTM | 7.126 |
| Gross Profit TTM (in USD) | 146.308M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Establishment Labs Holdings Inc
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.
11401 century oaks terrace, Austin, TX, United States, 78758
800 924 5072
Employees: 1004
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. Juan Jose Chacon Quiros | Founder, CEO & Exec. Director | 1972 |
| 2. | Mr. Rajbir Singh Denhoy | Chief Financial Officer | 1970 |
| 3. | Mr. Paul D. Rodio | Chief Operating Officer | 1966 |
| 4. | Mr. Roberto de Mezerville | Chief Technology Officer | 1981 |
| 5. | Mr. S. Ross Mansbach | Gen. Counsel & Chief Compliance Officer | NA |
| 6. | Mr. Jeffrey Clark Bettinger | Global Head of People | NA |
| 7. | Mr. Salvador Santos Dada | Chief Operating Officer (Medical Leave of Absence) | 1983 |
| 8. | Dr. Heather Brennan | Head of U.S. Commercial Operations | NA |
| 9. | Ms. Neeta Toprani | Corp. Sec. | NA |
| 10. | Mr. Juan Jose Chacon Quiros | Founder, CEO & Executive Director | 1972 |
Peers
Sector: Healthcare
Industry: Medical Devices
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ABT
Abbott Laboratories |
+0.020 0.023% | 87.195 | 25.970 | 17.241 | 3.570 | 3.200 | 3.805 | 16.753 |
|
SYK
Stryker Corporation |
+1.700 0.580% | 295 | 44.070 | 24.938 | 5.509 | 6.118 | 6.050 | 25.731 |
|
MDT
Medtronic PLC |
+4.200 5.695% | 77.12 | 26.600 | 15.873 | 3.354 | 2.083 | 3.897 | 14.117 |
|
BSX
Boston Scientific Corp |
+0.010 0.021% | 47.81 | 31.490 | 17.241 | 4.407 | 3.650 | 4.878 | 19.194 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
|---|---|---|---|---|---|
| Income Before Tax | -58.022M | -84.628M | -78.583M | -72.824M | -39.712M |
| Minority Interest | - | - | - | - | - |
| Net Income | -51.064M | -84.596M | -78.502M | -75.209M | -41.139M |
| Selling General Administrative | 165.069M | 139.806M | 143.541M | 125.984M | 92.229M |
| Gross Profit | 146.308M | 109.525M | 106.977M | 106.595M | 85.404M |
| Reconciled Depreciation | 10.474M | 7.577M | 4.633M | 4.339M | 4.124M |
| Ebit | - | -63.799M | -63.19M | -39.658M | -25.14M |
| Ebitda | -32.766M | -56.222M | -58.307M | -42.748M | -31.387M |
| Depreciation And Amortization | - | 7.577M | 4.883M | -3.09M | -6.247M |
| Operating Income | -39.008M | -49.987M | -65.026M | -39.658M | -25.14M |
| Other Operating Expenses | 250.084M | 216.012M | 230.177M | 201.358M | 151.822M |
| Interest Expense | 25.256M | 20.829M | 15.393M | 11.76M | 9.062M |
| Tax Provision | -6.958M | -0.032M | 3.243M | 2.385M | 1.427M |
| Interest Income | 0.423M | 1.477M | 0.541M | 0.087M | 0.023M |
| Net Interest Income | -24.833M | -19.352M | -12.714M | -11.673M | -9.039M |
| Income Tax Expense | -6.958M | -0.032M | -0.081M | 2.385M | 1.427M |
| Total Revenue | 211.076M | 166.025M | 165.151M | 161.7M | 126.682M |
| Total Operating Expenses | 185.316M | 159.512M | 172.003M | 146.253M | 110.544M |
| Cost Of Revenue | 64.768M | 56.5M | 58.174M | 55.105M | 41.278M |
| Total Other Income Expense Net | -19.014M | -34.641M | -13.557M | -33.166M | -14.572M |
| Net Income From Continuing Ops | -51.064M | -84.596M | -71.522M | -75.209M | -41.139M |
| Net Income Applicable To Common Shares | - | - | - | -75.209M | -41.139M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
|---|---|---|---|---|---|
| Total Assets | 357.167M | 346.831M | 268.641M | 211.061M | 139.529M |
| Intangible Assets | 9.942M | 11.683M | 7.987M | 4.608M | 4.371M |
| Other Current Assets | 11.26M | 8.922M | 8.009M | 11.543M | 2.641M |
| Total Liab | 333.62M | 293.736M | 250.246M | 219.246M | 88.79M |
| Total Stockholder Equity | 23.547M | 53.095M | 18.395M | -8.185M | 50.739M |
| Other Current Liab | 24.908M | 34.23M | 12.917M | 16.549M | 16.243M |
| Common Stock | 433.378M | 420.364M | 315.634M | 223.637M | 219.737M |
| Capital Stock | 433.378M | 420.364M | 315.634M | 223.637M | 219.737M |
| Retained Earnings | -495.756M | -444.692M | -360.096M | -281.594M | -206.385M |
| Good Will | 1.209M | 1.209M | 0.465M | 0.465M | 0.465M |
| Other Assets | - | - | - | 1.29M | 0.558M |
| Cash | 75.572M | 90.347M | 40.035M | 66.355M | 53.415M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 82.142M | 68.278M | 57.15M | 38.959M | 31.889M |
| Current Deferred Revenue | - | 1.749M | 1.836M | 1.688M | 0.769M |
| Net Debt | 188.895M | 134.947M | 152.189M | 112.306M | 0.391M |
| Short Term Debt | 14.125M | 1.514M | 0.773M | 0.688M | 0.402M |
| Short Long Term Debt | 12.413M | - | - | - | - |
| Short Long Term Debt Total | 264.467M | 225.294M | 192.224M | 178.661M | 53.806M |
| Other Stockholder Equity | 84.77M | 74.138M | 60.894M | 47.057M | 33.73M |
| Property Plant Equipment | - | - | - | 51.092M | 20.864M |
| Total Current Assets | 249.94M | 243.037M | 174.901M | 149.904M | 113.271M |
| Long Term Investments | - | - | - | - | - |
| Short Term Investments | - | - | - | - | - |
| Net Receivables | 77.497M | 65.002M | 46.918M | 35.423M | 24.437M |
| Long Term Debt | 247.522M | 219.577M | 188.739M | 175.461M | 51.906M |
| Inventory | 85.611M | 78.766M | 79.939M | 36.583M | 28.407M |
| Accounts Payable | 43.109M | 44.76M | 41.624M | 20.034M | 14.475M |
| Accumulated Other Comprehensive Income | 1.155M | 3.285M | 1.963M | 2.715M | 3.657M |
| Non Currrent Assets Other | 16.122M | 7.313M | 4.702M | 1.29M | 0.558M |
| Non Current Assets Total | 107.227M | 103.794M | 93.74M | 61.157M | 26.258M |
| Capital Lease Obligations | 4.532M | 5.717M | 3.485M | 3.2M | 2.302M |
| Long Term Debt Total | - | - | - | - | - |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
|---|---|---|---|---|---|
| Investments | - | -15.611M | -24.547M | -34.791M | -7.163M |
| Total Cashflows From Investing Activities | -7.028M | - | - | -34.791M | -7.163M |
| Total Cash From Financing Activities | 40.434M | 125.895M | 86.227M | 100.255M | 4.052M |
| Net Income | -51.064M | -84.596M | -78.502M | -75.209M | -41.139M |
| Change In Cash | -14.775M | 50.312M | -26.32M | 12.94M | -31.108M |
| Begin Period Cash Flow | 90.347M | 40.035M | 66.355M | 53.415M | 84.523M |
| End Period Cash Flow | 75.572M | 90.347M | 40.035M | 66.355M | 53.415M |
| Total Cash From Operating Activities | -50.89M | -58.516M | -88.513M | -52.166M | -27.532M |
| Depreciation | -9.563M | 7.577M | 4.883M | 4.339M | 4.124M |
| Other Cashflows From Investing Activities | -2.663M | -9.447M | -1.328M | -0.525M | -0.434M |
| Dividends Paid | - | - | - | 3.869M | 4.227M |
| Change To Inventory | -7.06M | -0.471M | -42.23M | -10.9M | -7.644M |
| Sale Purchase Of Stock | - | - | -0.484M | -0.004M | -0.356M |
| Other Cashflows From Financing Activities | -0.637M | 1.944M | 3.862M | 3.869M | 4.227M |
| Capital Expenditures | 6.049M | 8.528M | 24.547M | 34.266M | 6.729M |
| Change In Working Capital | -13.171M | -15.499M | -34.129M | -21.542M | -6.44M |
| Other Non Cash Items | 27.365M | 20.812M | 8.579M | 26.802M | 5.509M |
| Free Cash Flow | -56.939M | -64.63M | -113.06M | -86.432M | -34.261M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Baron Discovery Institutional | 2 months ago | 689845 |
| 2. | Baron Discovery Strategy | 2 months ago | 689845 |
| 3. | Loomis Sayles Small Cap Growth Instl | 3 months ago | 519946 |
| 4. | Brown Advisory Small-Cap Growth Inv | 2 months ago | 270318 |
| 5. | William Blair Small Cap Growth I | 3 months ago | 235230 |
| 6. | Brown Advisory US SmlrComs Dollar B Acc | 3 months ago | 223786 |
| 7. | Principal SmallCap Growth I Instl | 3 months ago | 219983 |
| 8. | CREF Total Global Stock Account R3 | 3 months ago | 214940 |
| 9. | Putnam Small Cap Growth A | 2 months ago | 152530 |
| 10. | JNL Multi-Manager Small Cap Growth A | 5 months ago | 139019 |
| 11. | GS Global SmallCap CORE Eq Base USD | 4 months ago | 131640 |
| 12. | Royce Small-Cap Trust | 2 months ago | 126375 |
| 13. | Eagle Small Cap Growth – Institutional | 2 months ago | 126092 |
| 14. | Royce Micro-Cap Trust | 2 months ago | 117034 |
| 15. | Jupiter Merian Glb Eq AbsRet I USD Acc | 5 months ago | 114576 |
| 16. | Royce Small-Cap Fund Invmt | 2 months ago | 107563 |
| 17. | American Funds SMALLCAP World A | 2 months ago | 102895 |
| 18. | Small Cap Core Equity Composite | 3 months ago | 100000 |
| 19. | DWS Small Cap Core S | 3 months ago | 100000 |
| 20. | Xtrackers MSCI World Swap ETF 1C | 5 months ago | 92294 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | BAMCO Inc | 5 months ago | 961226 |
| 2. | JW Asset Management, LLC | 5 months ago | 3061694 |
| 3. | RTW INVESTMENTS, LLC | 5 months ago | 2588831 |
| 4. | Brown Advisory Holdings Inc | 5 months ago | 1994298 |
| 5. | Findell Capital Management LLC | 5 months ago | 1130460 |
| 6. | Tyro Capital Management LLC | 5 months ago | 1077456 |
| 7. | Nantahala Capital Management, LLC | 5 months ago | 987689 |
| 8. | Morgan Stanley - Brokerage Accounts | 8 months ago | 838464 |
| 9. | The Goldman Sachs Group Inc | 5 months ago | 811536 |
| 10. | Capital Research Global Investors | 5 months ago | 807826 |
| 11. | Mudita Advisors LLP | 5 months ago | 699703 |
| 12. | Rice Hall James & Associates, LLC | 5 months ago | 651559 |
| 13. | William Blair Investment Management, LLC | 5 months ago | 639790 |
| 14. | First Light Asset Management, LLC | 5 months ago | 373082 |
| 15. | Royce & Associates, LP | 5 months ago | 358541 |
| 16. | Jane Street Group LLC | 5 months ago | 355475 |
| 17. | The Toronto-Dominion Bank | 8 months ago | 540024 |
| 18. | D. E. Shaw & Co LP | 5 months ago | 488040 |
| 19. | Summit Partners Public Asset Management, LLC | 5 months ago | 391850 |
| 20. | Woodson Capital Management, LP | 5 months ago | 375000 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...